Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 RYR Ankascin-568-R Offers Cardiovascular Health Benefits - Nutraceuticals World

What are you searching for?

Sign in
Products & Ingredients

RYR Ankascin-568-R Offers Cardiovascular Health Benefits

The red yeast rice formula supports heart health without the side effects of statins.

By: Lisa Olivo

, Rodman Media

Developed by AOR, RYR Ankascin -568-R is the only patented, clinically studied, regulatory compliant, and commercially available red yeast rice (RYR) extract free of monacolin K.
 
RYR is a natural health product typically used as a secondary option for statins, which are a class of drug prescribed by physicians for cardiovascular conditions such as high cholesterol. Despite being a natural product, conventional RYR products on the market have caused controversy due to the presence of monacolin K.
 
Monacolin K is naturally occurring statin and one of the active compounds present in RYR, which produces similar side effects to lovastatin, which is found in the cholesterol-lowering prescription drugs such as Mevacor. Some patients on prolonged or high doses of these statins can experience negative side effects including; myopathy, muscle symptoms including pain and weakness and rhabdomyolsis, a condition in which muscle fibers break down, releasing harmful substances into the bloodstream which can lead to liver and kidney damage.
 
RYR Ankascin -568-R is a new product from Canadian company, Advanced Orthomolecular Research (AOR), which unlike any other product on the market is completely free of monacolin K. RYR Ankascin -568-R is produced by fermenting rice with red yeast Monascus purpureus (a species of mold) and then subjecting it to a patented extraction process that removes the toxic bi-product citrinin. The new monacolin K-free RYR Ankascin -568-R product offers benefits targeting multiple symptoms of metabolic syndrome without the negative side effects associated with statin drug usage. RYR Ankascin -568-R has successfully completed two human clinical trials for cholesterol reduction, one preliminary study for blood pressure and one study for blood sugar reduction. Further, a small human pilot study has been completed for reducing various biomarkers of Alzheimer’s disease and additional studies are underway.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics